CEO Ulf Jungnelius to leave Isofol Medical on June 1, 2023
GOTHENBURG, Sweden, November 28, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that Chief Executive Officer Dr. […]
Staff change
Isofol Medical AB (publ) appoints Jenny Sundqvist as Chief Commercial Officer
GOTHENBURG, Sweden, December 10, 2021 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the appointment of Jenny Sundqvist
Isofol’s board appoints Dr. Jarl Ulf Jungnelius as new CEO of the company
GOTHENBURG, Sweden, November 13, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that the board
Isofol Announces Management Team Evolution with Appointment of Dr. Roger Tell as Chief Medical Officer
GOTHENBURG, Sweden, August 15, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the appointment of
Isofol Strengthens Executive Management Team with the Appointment of Roger Tell, MD, PhD, as Chief Scientific Officer and Senior Vice President of Clinical Development
GOTHENBURG, Sweden, November 19, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the recruitment of
Isofol appoints Gustaf Albèrt as Chief Financial Officer
Isofol Medical AB (publ) has recruited Gustaf Albèrt as Chief Financial Officer. With extensive experience from leading financial positions, Albèrt
Isofols appoints Sven Erickson as Chief Commercial Officer
In preparation for partnering negotiations with pharma companies Isofol Medical AB (publ) announces the appointment of Sven Erickson as Chief